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Stepwise regression procedures are often used to identify a 
small set of variables that serve as important predictors of 
clinical outcome and to construct prediction models based 
on those variables. Several theoretical and practical limita- 
tions of this process are discussed and highlighted with a 
variety of examples from published reports. Wider appre- 
ciation of these limitations should encourage the develop- 
ment of more relevant models, and thereby improve the 
quality of clinical prediction. 
(J Am Co11 Cardiol1989;14:12A-22A) 
The sciences do not try to explain; they hardly even try to 
interpret; they mainly make models . mathematical 
constrnct[s] which, with the addition of certain verbal 
interpretations, [describe] observed phenomena. The jus- 
tification of such a mathematical construct is solely and 
precisely that it is expected to work. 
John von Neumann 
99th annual meeting of the American Heart Association 
(centenary planners, take note). 
I have it on good authority that the world will end at 
exactly 1: 12 PM on Friday, November 13,2026 (1). This bold 
prediction derives from impressive empiric evidence gath- 
ered over the last 2,000 years (Fig. 1) demonstrating that 
world population (in billions of people) is a simple function 
of time (in years measured from the birth of Christ): 
Nobel prize-winning economist Wassily Leontief (3) re- 
cently lamented his colleagues’ slavish love affair with the 
modeling profession, noting that only 31% of reports pub- 
lished in the flagship journal of the discipline between 1972 
and 1981 contained any empiric data at all, and that only 1% 
contained new data generated on the author’s own initiative 
(Table 1). On the basis of these observations, he predicted 
that the economists would: 
Population = 179/(2026.87 - time)0.99 
. . continue to produce scores of mathematical models [by 
fitting] algebraic functions of all possible shapes to essen- 
tially the same sets of data without being able to advance, 
in any perceptible way, a systematic understanding of the 
structure and operations of [the real underlying] system. 
Since the discovery of this so called “Doomsday equation” 
in 1960, population growth has been just slightly ahead of 
schedule. The equation predicts a population of 5 billion in 
1989, but the Population Reference Bureau says that thresh- 
old was actually reached in 1987 (2). At this rate, world 
population is predicted to exceed 25 billion some time in the 
year 2020, and will go to infinity late in 2026, just before the 
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A recent survey (4) reveals that this practice is beginning 
to rub off on the medical profession. Only 8% of articles 
published in the journal Circulation during 1965 contained 
anything more than descriptive summary statistics, and none 
used the advanced methods common to prediction models. 
By 1985, however, 96% of published studies contained some 
form of statistical analysis, and 58% employed various 
advanced methods (Table 2). So, before we all cancel our 
plans for attending that AHA meeting, we would be well 
advised to take a closer look at the validity of the prediction 
process itself-a process that relies heavily on the use of 
statistical regression models. 
Address for renrints: George A. Diamond, MD, Cedars-Sinai Medical 
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There are many ways for clinical predictions based on 
these statistical models to go wrong. We can ask the wrong 
question, make the wrong assumptions, choose the wrong 
model, select the wrong variables, make the wrong measure- 
ments, compute the wrong parameters, and correlate the 
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3.0 
- N=179/(2026.87-TP.99 
- r=0.994 
Figure 1. The growth of world population over the last 8 
2,000 years. The curve is based on a least squares 
regression analysis of 24 independent estimates (1): r 
$ 
0 
represents the correlation coefficient. 
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wrong outcomes. For these reasons, Wasson et al. (5) 
recently proposed a number of standards that should be 
required of clinical prediction models, and concluded that a 
majority of validation studies failed to meet these standards. 
They observed that only 42% of published reports describing 
33 prediction models contained an adequate description of 
the model, only 34% described its error rate and only 6% 
described its impact on patient care. Are such poorly stan- 
dardized prediction models really relevant to individual 
patient decisions, or have the clinicians-like the econo- 
mists-become slaves to fashion? 
What Do We Know and How Well Do We 
Know It? 
How reproducible is stepwise regression? Clinically “im- 
portant” risk factors-the basis of most conventional pre- 
diction models-are usually identified by a familiar statistical 
procedure known as stepwise regression (6-8). This proce- 
dure was used, for example, to identify the important 
independent predictors for the development of 59 cases of 
acquired immunodeficiency syndrome (AIDS) among 1,835 
seropositive homosexual men over a median follow-up inter- 
val of 15 months. The following important factors were 
Table 1. Types of Reports in the American Economic Revieti* 
(1972 to 1981) 
Type of Report 
Model Data Percent 
_ 16 
t _ 53 
_ t 73 
t t 8 
t = yes; - = no. 
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identified: an increased number of T suppressor lympho- 
cytes, a paradoxically low titer of human immunodeficiency 
virus (HIV) antibody (indicating pre-existing immunodefi- 
ciency), a high titer of cytomegalovirus antibody and a 
history of sex with someone who subsequently developed 
AIDS. Kaposi’s sarcoma and opportunistic infections, fac- 
tors previously considered important, were not so identified 
in this study, and the authors thereby concluded that 
“[tlhese variables may be markers rather than determinants 
of disease progression” (7). But how certain can we be that 
the predictors identified by stepwise regression are really the 
important ones and that those not so identified are really not 
important? How fickle are such models? 
To answer this question, we followed up 598 postinfarc- 
tion patients undergoing stress electrocardiography and 
radionuclide ventriculography, and developed a stepwise 
logistic regression model to predict cardiac events (death or 
nonfatal infarction) over the next year based on a variety of 
observations derived from these tests (9). Stepwise regres- 
sion selected only 3 of 10 candidate variables for inclusion in 
the prediction model (peak exercise left ventricular ejection 
fraction, exercise duration and the magnitude of exercise- 
induced ST segment depression). We assessed the reproduc- 
ibiIity of this modeling process by repeating it multiple times 
Table 2. Types of Statistical Analysis in Circulation 
(1965 and 1985) 
Type of Statistical Analysis 196.5 (%) 1985 (7%) 
Descriptive 92 4 
Basic 8 38 
Advanced 0 58 
Descriptive = raw counts, mean values, standard deviations; Basic = I 
tests. 2 x ? tables, nonparametric tests. simple linear regression: Advanced = 
multiple linear regression, multiple comparisons. analysis of variance, logistic 
regression. survival analysis. 
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in samples ranging in size from 20 to 600 patients derived 
from the original study population by a procedure called 
bootstrap resampling (analogous to randomly sampling from 
an equivalent population of infinite size) (10). We quantified 
reproducibility at each sample size in terms of the proportion 
of bootstrap models that corresponded to the original refer- 
ence model according to several increasingly strict criteria: 
the proportion containing any of the three variables selected 
for inclusion in the reference model (the “important” vari- 
ables), the proportion containing the first variable selected 
for inclusion in the reference model (the “most important” 
variable, that is, peak exercise ejection fraction) and the 
proportion containing all three of the variables selected for 
inclusion in the reference model (the most relevant criterion 
with respect to accurate identification of the “important” 
variables). Reproducibility of stepwise regression decreased 
from 100% to 0% as a function of sample size and the 
strictness of the criterion employed (Fig. 2). Maximal repro- 
ducibility was only 30% with respect to the most relevant 
criterion at the 10% event rate observed in these postinfarc- 
tion patients, and decreased to 10% when we randomly 
deleted a proportion of the events to simulate a 1% event 
rate (similar to that in patients with suspected coronary 
artery disease). 
Role of sample size and event rate. These findings suggest 
that reliable prediction models require an adequate number 
of patients and events. To determine whether adequate 
numbers are actually employed, we reviewed 59 models 
published in six leading English language general medical 
journals since 1982 (11). Sample sizes ranged from 23 to 
121,964 subjects, and event rates ranged from 0.1% to 62%. 
We estimated the reproducibility of each model based on a 
regression equation derived from our bootstrap analysis. 
Reproducibility averaged 37 -+ 5% (range 1% to 100%) using 
all the important variables as the criterion. 
In one such study (lo), stepwise regression was used to 
identify the “important variables” predictive of subsequent 
death among 155 patients with hepatitis. Only 4 of 19 
candidate variables were so identified (malaise, ascites, 
serum bilirubin and the physician’s subjective estimate of 
outcome). However, when reproducibility was assessed 
using the same bootstrap resampling procedure we had used, 
stepwise regression failed to identify even one of these 
so-called “important variables” in 60% of 500 replicate 
models. 
In another study (12), stepwise regression models were 
constructed from 30 candidate variables in three indepen- 
dent random samples, each containing 528 patients and 55 
cardiac events, derived from a parent population of 2,113 
patients and 208 cardiac events. The three resultant models 
looked very different from one another. Although 16 dif- 
ferent variables were selected from the list of 30 candidates, 
only 2 of the 16 were common to all three models, and 7 
occurred in only one model. In fact, the “most important 
SAMPLE SIZE 
0 200 400 600 
SAMPLE SIZE 
Figure 2. Relation between sample size and the reproducibility of a 
stepwise logistic prediction model for an event rate of 10% (upper 
panel) and 1% (lower panel) among 598 postinfarction patients. 
Three criteria of reproducibility are illustrated in each panel (in- 
creasing in strictness from the uppermost curve to the lowermost 
curve): the proportion of models containing any of the “important 
variables” (upper curve), the proportion of models containing the 
“moot important variable” (middle curve) and the proportion of 
models containing all the “important variables” (lower curve). 
variable” in one model (presence of a ventricular gallop) did 
not appear at all in the other two, and the “most important 
variable” shared by them (radiographic cardiomegaly) did 
not appear anywhere in the other model. 
Given the statistical nature of the prediction process, the 
poor reproducibility of stepwise regression models should 
come as no surprise. The documentation manual (6) for a 
widely used software implementation of stepwise logistic 
regression, for example, contains the following “Note of 
Caution”: 
Stepwise variable selection can potentially be abused. When 
many variables are being examined, stepwise methods 
can easily find significant factors even when no real 
associations with the dependent variable exist. Model 
building can be ill-advised when the overall chi-square 
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statistic for testing all candidate variables jointly is not 
significant, indicating no evidence of regression. If a 
model is developed in this situation, chances are that it 
will not predict accurately on an independent sample. 
. In general, if there are m observations for the least 
frequent category of a binary response variable, you 
should not examine more than m/IO variables in order to 
derive a model that is somewhat reliable. 
Our confidence in these “somewhat reliable” models can 
be further degraded by baseline differences in the composi- 
tion of the reference population and in the operative defini- 
tions of the candidate clinical variables (l3), by a variety 
of cognitive and methodologic biases (l4), and even by 
shoddy performance on the part of the investigators (15). 
As a result, we would do well to emulate the weatherman 
who admits (if only to himself), “ . . . there’s a 40% chance 
of rain, and a 10% chance I know what I’m talking 
about!” (16). 
The More We Know, the Less There Is 
to Learn 
Routine clinical findings versus clinical prediction models. 
Clinical prediction models frequently ignore the hierarchical 
nature of clinical data acquisition (15,17). For example, 
peak exercise left ventricular ejection fraction is often re- 
ported to be the best predictor (and sometimes the on/y 
predictor) of survival in patients after myocardial infarction 
(18,19). Nevertheless, one does not thereby have license to 
ignore other readily available clinical information, such as 
symptoms and signs of heart failure or the level of ejection 
fraction at rest. Instead, the clinical value of any variable is 
properly judged only in terms of the increment of informa- 
tion it provides over that which is already known. As already 
noted, for example, peak exercise ejection fraction was the 
first variable selected by a stepwise regression model to 
predict coronary events among our postinfarction patients, 
and ejection fraction at rest did not provide a significant 
increment of information. As shown in Figure 3, however, 
when rest ejection fraction was forced into the regression 
model ahead of exercise ejection fraction, the former pro- 
vided a significant amount of information instead of the latter 
(20). In fact, knowing the baseline event rate is only 10% is 
really the best predictor of all. If you were to use this 
knowledge, and thereby predict that every one of these 
patients would remain event-free over the next year, you 
would be right in 90% of the cases. It is hard to improve on 
that level of performance. 
How much information does the prediction model add? 
Gill et al. (21) recently employed stepwise logistic regression 
to show that pulmonary uptake of thallium was the “best 
predictor of a cardiac event” in patients with known or 
suspected coronary artery disease, and thereby concluded 
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Figure 3. Incremental prognostic accuracy of rest left ventricular 
ejection fraction (rest EF) and peak exercise left ventricular ejection 
fraction (exercise EF) among 646 postinfarction patients. Prognostic 
accuracy is expressed in terms of the area under a receiver- 
operating characteristic (ROC) curve constructed from knowledge 
of event status and the probability of an event based on logistic 
regression of the individual rest-exercise ejection fraction values. 
An ROC area of 100% represents perfect discrimination, and an 
ROC area of 50% represents no discrimination. Discrimination 
based on both variables was no better than that based on rest 
ejection fraction alone. 
that this observation alone “ . . . should prompt consider- 
ation of aggressive therapy.” Because pulmonary uptake of 
thallium is a marker of left ventricular dysfunction, it is 
indeed likely to have prognostic value, but it is not very 
likely to remain ” . . . the most powerful independent pre- 
dictor of future cardiac events” (21) after appropriate con- 
sideration of numerous other highly correlated markers of 
function that are readily available to the clinician from the 
history and physical examination alone. 
Iskandrian et al. (22) recently reported that thallium 
scintigraphy identified a subset of patients at low risk for 
subsequent coronary events. They noted that the presence 
or absence of a clinical history of infarction also had prog- 
nostic value, but went on to say that, “[the prognostic value 
of a history of previous infarction] decreased considerably 
when it was adjusted for the scintigraphic predictors.” This 
statement turns the natural sequence of clinical data acqui- 
sition completely around. Most physicians appreciate that 
the clinical history contains important information (23). and 
would therefore be likely to know if there were a prior 
history of infarction before knowing the scintigraphic find- 
ings. The appropriate question to be modeled then is not, 
“what is the value of the history given the test result?” but, 
“what is the value of the test result given the history?“. 
Consequently, the recommendation to perform any diagnos- 
tic test should be predicated on evidence that it adds an 
increment of information to that which is already known. 
Cardiologists are not the only ones to overlook the 
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Figure 4. Discordance between the logistic prediction model based 
on rest and peak exercise left ventricular ejection fraction (LVEF), 
and the distribution of ejection fraction values for the 646 postin- 
farction patients in whom the model was derived. Logistic event 
probability (y axis) is expressed as a function of rest left ventricular 
ejection fraction (x axis) and peak exercise left ventricular ejection 
fraction (z axis). For each axis, values range from 0 to I. The 
ejection fraction data tend to be oriented at right angles to the 
general direction of the risk function, indicating a high correlation 
between rest and exercise values (r = 0.852). As a result, there are 
few patients in the regions of highest (left background) and lowest 
(right foreground) risk. 
hierarchical nature of clinical information. Specht et al. (24) 
followed up 142 patients with Hodgkin’s disease for 15 to 146 
months, and used multivariate analysis to determine that 
“tumour burden” (a derivative of tumor size and number of 
regions involved) was “the single most important prognostic 
factor for outcome after radiotherapy.” They reported that 
this derived variable replaced a number of well known and 
readily assessed prognostic factors such as mediastinal size, 
systemic symptoms and erythrocyte sedimentation rate. 
Even so, we should always question the relevance of any 
such model that fails to appreciate that the more we already 
know, the less there is to learn (17). 
The Lights Are on, but Nobody’s Home 
Failure to appreciate the hierarchical nature of clinical 
data acquisition produces some very unrealistic expecta- 
tions. Figure 4, for example, is a graphic representation of a 
logistic model to predict the annual risk of cardiac events 
among postinfarction patients based on rest and peak exer- 
cise left ventricular ejection fraction. According to this 
model, these two variables alone are capable of stratifying 
risk over a very wide range-from <lo/o (the lower fore- 
ground corner) to >90% (the upper background corner). 
Common sense, however, leads us to suspect that the 
component variables are highly correlated, and visual in- 
spection confirms this suspicion. In fact, the data tend to 
cluster along a line oriented perpendicular to the general 
direction of the risk function itself. As a result, despite the 
E 501 
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Figure 5. Inverse relation between the frequency of various thresh- 
old levels of rest left ventricular ejection fraction (in percent) on the 
x axis and the event rate associated with that threshold on the y axis 
for 646 postinfarction patients. 
apparent power of this model, there are actually no patients 
with the extreme values of risk it is capable of predicting. 
The lights are on, so to speak, but nobody’s home (25). 
There’s No Free Lunch 
In such cases, investigators sometimes adjust the thresh- 
old criterion of the component variables in an attempt to 
identify a “high risk” subgroup of suitable size (18). This 
works, but only up to a point. As shown in Figure 5, the 
event rate was 33% among postinfarction patients with a rest 
ejection fraction <20%, but only 3% of the patients had such 
extreme values. In contrast, although 42% of the patients 
had a rest ejection fraction <50%, the event rate in this 
group was only 14%-not much higher than the baseline 
event rate of 10%. The simple truth is that powerful predic- 
tors are not very common, and common predictors are not 
very powerful (18), and we cannot circumvent this truth by 
arbitrary threshold adjustments. There’s no free lunch. 
On the other hand, we can often improve the accuracy of 
a prediction model by adding more variables. In conjunction 
with our study of the reproducibility of clinical prediction 
models (9), for example, we first constructed a logistic 
prediction model based on the “most important variable” 
alone (peak exercise ejection fraction), then added the “next 
most important variable” into the model (exercise duration) 
and finally added the “last important variable” (electrocar- 
diographic ST depression). At each step, there was an 
increase in the discriminant accuracy of the resultant pre- 
diction model-measured in terms of area under a receiver 
operating characteristic (ROC) curve-from 68 to 74%. 
Unfortunately, there are several problems with this ap- 
proach. 
Overfitting. The more data we put into any model, the 
more it will reflect the particular population on which it is 
based, and the less it will be applicable to a new population. 
A dramatic illustration of such overfitting is provided in the 
analysis of an industrial quality control problem (26). The 
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Table 3. Variance Reduction During Stepwise 
Regression Analysis 
Explained Variance 
Regression Step (%I 
I 21.2 
3 48.8 
6 7x.s 
9 94.7 
12 98.0 
15 99.57 
18 99.86 
21 99.9969 
The explained variance is the proportion of total least squares variance in 
the outcome measure (in percent) accounted for by all the variables entering 
into the regression equation at that step. 
engineers performing this analysis first identified 16 factors 
they considered to be potential determinants of quality for a 
production process. Each of the 16 factors was expressed as 
a continuous variable, along with its reciprocal, its square 
and the reciprocal of its square. Stepwise regression was 
then performed using the set of 64 raw and derived variables 
as input and the observed service life for 22 production 
batches as outcome. The resultant stepwise regression 
model explained about 80% of the variation in service life. 
So far, so good. In the course of verifying their results, 
however, the engineers repeated the analysis on a fictitious 
set of data generated completely at random. To their sur- 
prise, the resultant model-based on 21 of 64 random 
variables-explained 99.9969% of the variance in service life 
(Table 3). 
Murphy (27) has a ready explanation for this paradox. He 
says: 
. . . we can usually devise a model that will fit the data 
perfectly; but in general we will find that in doing so we 
have invoked as many structures . . in the model as we 
have data points In the process, the model-fitting 
has succeeded brilliantly at a technical level but has failed 
totally in the scientific endeavor . . We have replaced a 
set of 20 data by an equation containing 20 parameters. 
Accordingly. the engineers discovered that only 21 vari- 
ables and one regression constant were required to describe 
22 outcomes to within a hair’s breadth of perfection. You 
may recall, we were cautioned about including more than 
one variable for every 10 outcomes in our models (6). 
Robbing Peter to pay Paul. As we have just seen, the 
overall quality of a conventional regression model (measured 
in terms of explained variance) tends to increase as more 
variables are added. Because newly added variables contain 
some noise as well as information, however, the precision of 
individuai predictions (measured in terms of the average of 
their individual variances) can become worse at the same 
I 
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Figure 6. Inverse relation between the accuracy and precision of a 
logistic prediction model based on 646 postinfarction patients. 
Accuracy (upward bars) is expressed as area under a receiver- 
operating characteristic curve constructed from the set of logistic 
outcome probabilities, and precision (downward bars) is expressed 
as the average variance of the individual probabilities. 
time the uccuracy of these predictions (measured in terms of 
overall discrimination) improves. If this sounds confusing, 
recall that the sum of the squares ([2 x 21 + [3 x 31) is not 
equal to the square of the sum ([2 + 31 x [2 + 31). Thus, 
although discriminant accuracy increased from 68% for a 
prediction model based only on peak exercise ejection 
fraction to 74% for one based also on exercise duration and 
ST depression, the variance associated with the individual 
predictions increased also from 28% to 54% (Fig. 6). The 
improvement in accuracy was, therefore, bought at the 
expense of precision. We wind up robbing Peter to pay Paul. 
A show of confidence. This leads us to another commonly 
overlooked aspect of the nature of prediction. Although we 
can confidently predict the outcome of a series of honest 
coin tosses with high accuracy, we always remain totally 
ignorant about the outcome of the very next coin toss 
(thereby assuring the continued prosperity of Las Vegas and 
Atlantic City). In the same way, predicting the average risk 
for a group of patients (knowing how many will die) is very 
different from predicting the spec$c risk for an individual 
member of that group (knowing who will die). 
Figure 7 illustrates a logistic model for predicting coro- 
nary events based on peak exercise ejection fraction alone 
(28). The innermost line is the average risk, and the white 
band surrounding that line is the 95% confidence interval for 
that risk (29). The superimposed data points are for groups of 
patients divided by decile of ejection fraction. Note how 
they cluster around this confidence interval. The gray band 
surrounding this group confidence interval is the 95% confi- 
dence interval for an individual prediction (often called a 
tolerance interval). This tolerance interval is much wider 
than the confidence interval. According to this model then, 
the event rate for a particular patient with an ejection 
fraction of 40% ranges somewhere between 30% and O%- 
between Heaven and Earth. 
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Figure 7. The (group) confidence interval and (individual) tolerance 
interval for a logistic prediction model based on peak exercise left 
ventricular ejection fraction (LVEF) in 646 postinfarction patients. 
The plotted points are for groups divided into deciles according to 
the value of ejection fraction. Numbers at the bottom of the graph 
represent the number of patients in each decile. Note that the group 
data cluster within the confidence interval and that the tolerance 
interval is substantially wider than the confidence interval. 
The wimp factor. In the same way that statistical signif- 
icance (p values) has nothing to do with clinical significance 
(biologic importance), the statistical goal of modeling (vari- 
ance reduction) has nothing to do with the clinical goal 
(rational decision making). Consider the two hypothetical 
prediction models summarized in Table 4. Each model 
stratifies patients into a “high risk” group, an “intermediate 
risk” group and a “low risk” group. A conventional statis- 
tical algorithm based on the principle of variance reduction 
would prefer Model A because the associated variance is 4% 
less than that for Model B (30). On the other hand, a less 
conventional (but readily justified) algorithm based on the 
principle of uncertainty reduction (31,321 would prefer 
Model B because the associated uncertainty is 7% less than 
that for Model A. Moreover, clinicians might well prefer the 
120 unequivocal, categorical predictions of Model B to the 
200 indecisive probabilistic predictions of Model A. Nobody 
likes a wimp. 
Clinical Validation and Statistical Tribulation 
Just as the physicist is free to model the timing of the next 
lunar eclipse on the equations of Einstein rather than those 
of Newton, the statistician is free to model a clinical predic- 
tion problem on the principle of uncertainty reduction rather 
than variance reduction. Aside from the added computa- 
tional work involved, these subjective choices are little 
cause for concern, so long as we all agree to submit the 
resultant models to an unbiased empirical test of their 
validity. 
Selection bias. The real problem occurs when the choices 
themselves intrude on this process of clinical validation. For 
example, Ruddy et al. (33) recently developed a quantitative 
model to analyze dipyridamole-thallium images for “the 
detection of coronary disease.” Their study group, however, 
was inappropriate to this purpose for two reasons (15,34-38). 
First, the authors chose not to exclude 28 of the 53 patients 
with coronary disease in whom “detection” could not be at 
issue because they had a previous myocardial infarction. 
This questionable practice of biasing the study group toward 
the “sickest of the sick” is well known to overstate test 
sensitivity (15,34,38). Second, the authors chose to define 
the normal range of their variables in 13 young, healthy 
volunteers. Restricting the referent group in this way to the 
“wellest of the well” overstates test specificity (14,34,38). 
The potentially avoidable selection biases introduced by 
subjective choices such as these serve to undermine many 
conventional clinical validations. 
Prospective validation studies often employ a split sample 
design. For example, Mark et al. (39) recently proposed a 
multivariate statistical model based on only three variables 
to perform prognostic assessments of patients undergoing 
electrocardiographic stress testing for suspected coronary 
artery disease. Their study group was likely to be biased, 
however, because it was limited to patients referred for 
coronary angiography-a judgment that relies at least in part 
on the results of the electrocardiographic stress test itself 
(40,41). A split sample design would not protect the study 
from the distortions introduced by this selection bias be- 
cause each of the split samples would be similarly biased. 
Thus, multiple random samples from a biased population are 
Table 4. Comparison of Prediction Models Based on Variance and Uncertainty 
Model A Model B 
Group Events Pts Variance Uncertainty Events Pts Variance Uncertainty 
1 90 100 9 47 60 60 0 0 
2 50 100 2s 100 90 180 45 180 
3 10 100 9 47 0 60 0 0 
Total 150 300 43 194 150 300 45 180 
Events = number of events; Pts = number of patients: Variance = npq where n is the number of patients, p is the event rate (eventsipts) and q is l-p: 
Uncertainty = n[p/np t qlnq]//n2 (based on Shannon’s information [31]). 
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very likely to be similarly biased, whereas a single random 
sample from even an unbiased population is likely not to be 
representative of that population (the empiric bootstrapping 
technique discussed earlier deals with the latter difficulty, 
but not the former). 
Calibration versus resolution. This problem is only par- 
tially circumvented by using measures that are inherently 
insensitive to selection bias, such as the area under an ROC 
curve (42-44). Thus, because ROC area is independent of the 
defining threshold of discrimination, it assesses the resolu- 
tion of a prediction model, but not its calibration. This is 
especially troublesome when dealing with prediction models 
that output a quantity naturally interpreted as a probability. 
Suppose we develop a perfectly calibrated probabilistic 
prediction model in a population with a 50% outcome event 
rate. By that, I mean every time we say a patient’s risk is 
x%, exactly x% of such patients actually experience the 
outcome event. For this to happen, the predicted event rate 
must average 2/3 among those with events versus 113 among 
those without events, and the distribution of the predictions 
in each case must be triangular in shape (35). The resolution 
of a perfectly calibrated model such as this will be only 82% 
(45). 
I have always had difficulty with the concept of perfect 
resolution of a probability, anyway. For instance, if every- 
one with a “probability” ~0.1 dies and everyone with a 
probability ~0.1 survives, then the resolution of this model 
is superb, but its calibration is awful. To my mind, a 
probability, by definition, should be well calibrated (it should 
mean what it says), whereas an index of discrimination, 
being arbitrarily defined, should be well resolved (it should 
say what it means). 
The price of perfection. Even if we agree to trade resolu- 
tion for calibration, we are still not out of trouble. Suppose 
we have a perfectly calibrated model to assess the risk of 
dying over the next 24 h in patients with acute myocardial 
infarction. If given the chance, clinicians are very likely 
to use such perfect risk assessments in their day to day 
decision making. Let us assume there is some lower 
threshold of risk, 1, below which the clinician chooses to 
delay treatment and reassess the risk 24 h later. Assume 
further that risk increases over the next 24 h as a result 
of this delay. Similarly, assume there is an upper thresh- 
old of risk, U, above which the patient is so sick and the 
clinician’s choice of treatment so aggressive that risk also 
increases over the next 24 h. Between these two thresholds, 
there lies a window of opportunity within which today’s 
treatment reduces tomorrow’s risk. An example of one 
such system is illustrated in Figure 8. The x axis represents 
the risk on day d (today), and the y axis represents the 
risk on day d + 1 (tomorrow). Suppose that a particular 
patient’s risk on day 1 is 30%. To predict the risk on day 2 
we need only select the 30% value on the x axis, move 
vertically until we intersect the graph, and read off the 
1 
0 
RISK ON DAY d 
1 
Figure 8. A hypothetical perfect probabilistic prediction model. 
The x axis is the risk of dying on day d; the y axis is the risk of dying 
on day d t 1 (the next day). See text for complete discussion. 
next day’s value on the y axis. To predict the risk on 
day 3, we transfer the day 2 value on the y axis to the x axis, 
move vertically until we intersect the graph, and again read 
off the next day’s value on the y axis. By continuing this 
recursion, we can predict with assurance that the risk on 
day 8 will be exactly 5.6% given a risk of 30% on day 1. Just 
as in Newtonian physics, the future is completely deter- 
mined by the past. 
We have only recently come to recognize that simple 
deterministic systems such as this are prone to some 
rather bizarre behavior. For example, suppose we change 
our initial risk assessment by an arbitrarily small amount- 
say, 1 part in 300. Table 5 summarizes what happens for 
the two series of predictions under these circumstances. 
Although the differences are trivial over the first few 
days, by day 10 they are dramatic; risk is 3.2% in one 
case and 96.7% in the other. Mathematicians call this phe- 
Table 5. Chaotic Model of Risk After Myocardial Infarction 
Series 1 Series 2 
Hospital Day (%) (%) 
I 30.0 30. I 
2 96.6 96.5 
3 81.6 81.4 
4 17.6 17.1 
5 80. I 78.5 
6 13.8 10.2 
7 67.1 52.0 
8 5.6 43.3 
9 29.5 71.9 
10 96.7 3.2 
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Figure 9. Ceci n’est pas une pipe by Rent? Magritte (1926). 
nomenon sensitive dependence on initial conditions. It is 
the hallmark of truly chaotic (as contrasted to random) 
physical processes such as fluid turbulence, and the reason 
why we will never be able to predict tomorrow’s weather- 
or our patient’s prognosis-with anything approaching 
certainty (46). 
Representations of Reality 
Imagine Santa Claus has unstable angina. The vivid 
mental image this elicits is based on what Tufts University’s 
Daniel Dennett (47) calls an “intentional object”: 
Just as one might set out to learn all there is to be learned 
about Santa Claus, the intentional object, so one might set 
out to learn all there is to be learned about [other] 
intentional objects. . . . Note that there are truths and 
falsehoods about Santa Claus. It is true that Santa Claus 
has a white beard and drives a flying sleigh, false that he 
is tall and thin. Focusing on intentional objects like this 
does not require a presumption of fiction or falsehood. 
Consider the difference between setting out to learn all 
there is to know about Queen Elizabeth II, and setting out 
to know all there is to know about Queen Elizabeth II, the 
intentional object constructible from the beliefs of British 
school children under the age of IO. The latter investiga- 
tion might prove both more interesting and more useful 
than the former. 
Clinical cardiology is replete with such “interesting and 
. . . useful” intentional objects: p < 0.05, the high risk 
patient, hibernating myocardium, the 50% coronary steno- 
sis, the positive stress test, main left equivalence, the culprit 
vessel, the total ischemic burden, the stuttering infarction, 
the angina1 equivalent, silent ischemia, critical aortic steno- 
sis-and, of course, unstable angina. Don’t get me wrong. I 
do not mean to imply that these intentional objects are not 
real; each, in fact, is “ . . . at least as real as Santa Claus” 
(47). On the other hand, we would do well to avoid confusing 
intentional reality with physical reality. This, I think, is the 
point of the surrealistic pipe painting by Rene Magritte 
bearing the seemingly paradoxical inscription: “Ceci n’est 
pas une pipe” (Fig. 9). The paradox cannot be resolved until 
you realize it is in fact not a pipe, but only a picture of a pipe 
(48). 
0 
1960 1970 1980 1990 2000 2010 2020 
YEARS (A.D.1 
Figure 10. Extrapolation of the Doomsday equation between AD 
1960 and AD 2020. The stippled band represents a conventional 95% 
confidence interval about the prediction line based on the known 
magnitude of error associated with the parameters of the equation. 
Sometimes we don’t even get the picture. Christie’s, the 
New York art house, recently sold a piece of conceptual art 
entitled Ten Thousand Lines Ten Inches Long, Covering a 
Wall Evenly. The buyer didn’t actually get the work itself, 
but only a representation of the work-a set of instructions 
allowing him to render it physically on the wall of his choice. 
Similarly, clinical prediction models are not the reality, but 
only conceptual representations of that reality: Ten Thou- 
sand Predictions Three Variables Long, Covering a Patient 
Even/y. Many good models (such as the variance reduction 
methods used to identify “important variables”) are clini- 
cally irrelevant. Many others, while relevant, are just no 
good-in the spirit exemplified by this essay’s epigram, they 
simply do not work. No wonder then that few published 
prediction models have actually diffused into routine clinical 
practice. 
Even though we will never be able to forecast long-range 
weather patterns very accurately, we can do reasonably well 
over the short haul (49). I therefore feel sure that similar, 
short-range, clinically relevant, statistical prediction models 
will be developed, validated and deployed. To their credit, 
the Health Care Financing Administration appreciates the 
limitations of logistic regression models, and plans to sup- 
plement a conventional split-sample analysis with empiric 
bootstrapping procedures to define tolerance intervals for 
hospital-specific logistic mortality estimates among Medi- 
care beneficiaries (50). Thus, given a good model, adequate 
data and enough time, we might yet be able to predict the 1 
day outlook of postinfarction patients with close to 100% 
reliability (although the computer programs might take 2 
days to come up with the prediction). 
But what about Doomsday? Do we still have the time? 
Well, 1 am happy to say I neglected a few inconsistencies in 
that model. First, there is reason to suspect that the popu- 
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lation doubling time for our species cannot be much less than 
9 months, no matter how good the fit of the data (51). 
Second, if we use the Doomsday equation to calculate 
backward in time, we discover that Adam (N = 1) appeared 
(on the sixth day of creation) some 233 billion years ago. Eve 
(N = 2) appeared 115 billion years later (that same day!) and 
bore her first child (N = 3) when she was 39 billion years old. 
These estimates, being slightly in excess of those advocated 
by both the physicists and the creationists, serve to remind 
us that the model’s parameters are not known with certainty. 
To be specific, there is a 7.8% error in the constant appearing 
in the numerator, a 0.9% error in the exponential constant 
appearing in the denominator and 0.3% error in the linear 
constant in the denominator representing the actual date of 
doomsday (1). As a result of these seemingly small individual 
errors, the aggregate error of the outcome prediction be- 
comes huge when we extrapolate even 3% beyond the range 
of our data (Fig. 10). Based on these errors, then, the lower 
bound of a 95% confidence interval for the world population 
overlaps a value of zero in the year 20lLmeaning there’s a 
chance our species will dwindle to extinction a full decade 
before the Doomsday crush. The future ain’t what it used to 
be. 
1 acknowledge the efforts of Jeffery Work, MD and John Ferguson, MD in 
performing many of the data analyses discussed in this review. 
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